Charlotte Batts
Biographic Data
| ID | 9066446 |
|---|---|
| NAME | Charlotte Batts |
| GIVEN NAMES | Charlotte |
| FAMILY NAME | Batts |
| SIGNATURE | BATTS C |
| AFFILIATIONS | Médecins Sans Frontières |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimens
Clinical trials are considered to be the largest contributor to pharmaceutical development costs. However, public disclosure of the costs of individual clinical trials is rare. Médecins Sans Frontières (MSF) sponsored a phase 2b-3 randomised controlled trial (TB-PRACTECAL), which identified a new treatment regimen for drug-resistant TB. We aimed to analyse the costs of undertaking a pivotal clinical trial conducted in relatively low-resource heal…
No prominent works on this page.
Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimens
Clinical trials are considered to be the largest contributor to pharmaceutical development costs. However, public disclosure of the costs of individual clinical trials is rare. Médecins Sans Frontières (MSF) sponsored a phase 2b-3 randomised controlled trial (TB-PRACTECAL), which identified a new treatment regimen for drug-resistant TB. We aimed to analyse the costs of undertaking a pivotal clinical trial conducted in relatively low-resource heal…
Accounting (1 work) · Bedaquiline (1 work) · Biosimilars and Bioanalytical Methods (1 work) · Business (1 work) · Clinical trial (1 work) · Cost effectiveness (1 work) · Cost–benefit analysis (1 work) · Health economics (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Internal Medicine (1 work)